ASHP Guidelines on Medication-Use Evaluation

Afanasjeva, Janna; Burk, Muriel; Cunningham, Francesca Fran; Fanikos, John; Gabay, Michael; Hayes, Genevieve Jeni; Masters, Patricia L; Rodriguez, Ryan; Sinnett, Mark J.

doi:10.1093/ajhp/zxaa393

Cited by 16 publications

(11 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It was useful to reflect on the problems and pitfalls to avoid that were outlined in the recently updated ASHP guidelines on medication-use evaluation and ensure that factors such as having medical leadership and support, taking an interdisciplinary approach and excellent communication were in place [ 5 ]. Ensuring governance structures were in place was key for transparency of work undertaken, as well as an enabler to decide prioritisation of projects that align with organisational goals.…”

Section: Discussionmentioning

confidence: 99%

“…The introduction of the MUP pharmacist to professionally lead project design development has seen the development and implementation of projects with a robust framework that have the potential to demonstrate impact on cost and quality. As outlined in the ASHP guidelines it is important to follow up, evaluate initial actions, be flexible to adjust the action plan if necessary and keep sight of improvement goals in order to demonstrate impact on cost and quality outcomes [ 5 ].…”

Section: Discussionmentioning

confidence: 99%

“…There are several ways to ensure optimisation and quality use of medications, and these include medication-use evaluations, quality improvement initiatives and research studies [ 4 ]. The American Society of Health-System Pharmacists (ASHP) in their 2021 guideline on medication-use evaluation describe the essential elements of the process for health care organisations [ 5 ]. A systematic and interdisciplinary approach to optimise patient outcomes using ongoing evaluation to improve medication utilisation is the main goal.…”

Section: Introductionmentioning

confidence: 99%

“…Problems and barriers were identified in the ASHP guideline [ 5 ] with an explanation how to address, that included the need for: Authoritative medical staff support; Clear structure and leadership with clear definition of roles, responsibilities and accountabilities; Excellent communication and the importance of involvement of key stakeholders; Excellent documentation summarising findings and outlining an action plan; An interdisciplinary approach; Follow up and evaluation of initial actions, flexibility to adjust the action plan if necessary and keeping sight of improvement goals; Education regarding not only how to conduct these studies but also education when implementing new processes. …”

Section: Introductionmentioning

confidence: 99%

“…Problems and barriers were identified in the ASHP guideline [5] with an explanation how to address, that included the need for:…”

mentioning

confidence: 99%

See 4 more Smart Citations

Medication Utilisation Program, Quality Improvement and Research Pharmacist—Implementation Strategies and Preliminary Findings

et al. 2021

View full text Add to dashboard Cite

Judicious use of medicines that considers evidence-based practice, together with cost-effectiveness, is a priority for all health care organisations. We describe an initiative to lead a Medication Utilisation Program, incorporating medication quality improvement and research activities. In August 2020 an advanced pharmacist position was implemented to lead the Program. The purpose was to provide oversight and facilitate initiatives promoting medication optimisation to create sustainable change in practice. A strategic plan was developed with key performance indicators. A governance structure was implemented with relevant reporting mechanisms. Strategic planning and collaboration with medical, nursing and allied health professionals has seen the successful implementation of seven codesigned medication-use evaluations and eight quality improvement projects centred around patient safety, quality and value-based care. Several research studies have been designed with subsequent commencement of pharmacists enrolled in university Research Higher Degree programs. Cost containment initiatives have realised potential savings approximating AUD 250,000. Educational programs included protocol design, ethics approvals and report writing. Key success criteria for a Medication Utilisation Program include dedicated pharmacist resources, structured governance and reporting mechanisms. Alignment of study complexity with staff experience and interdisciplinary collaboration are also critical.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

“…Problems and barriers were identified in the ASHP guideline [5] with an explanation how to address, that included the need for:…”

mentioning

confidence: 99%

See 3 more Smart Citations

Medication Utilisation Program, Quality Improvement and Research Pharmacist—Implementation Strategies and Preliminary Findings

et al. 2021

View full text Add to dashboard Cite

show abstract

Securing administrative leadership commitment for anticoagulation stewardship programs

May,

Triller,

Inglis

et al. 2024

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Anticoagulation is a leading cause of medication‐related harm. As a result, there is increasing recognition of the importance of the development of anticoagulation stewardship programs to ensure safe and effective anticoagulation use across health care settings. Securing administrative leadership support to build such programs is a necessary first step but is often a significant barrier to implementation. Herein, we present a structured approach to guide providers advocating to leadership for stewardship programs at their institutions. We divide the approach into four phases: (1) Build the foundation, (2) Select stewardship initiatives, (3) Develop implementation plans, and (4) Prepare and present a business plan. Within each phase, we outline specific actions to consider, all leading up to the end goal of creating a compelling business plan to generate administrative leadership buy‐in. We also provide resources to promote the understanding of institutional needs as well as broader trends across health systems that influence stewardship program development. Our aim is to provide stewardship advocates with the tools to effectively secure leadership support to facilitate the development of Anticoagulation Stewardship Programs across all health care institutions.

show abstract

Medication Use Evaluation of High-Dose Long-Term Opioid De-prescribing in Multiple Veterans Affairs Medical Centers

et al. 2022

View full text Add to dashboard Cite

ASHP Guidelines on Medication-Use Evaluation

Cited by 16 publications

References 1 publication

Medication Utilisation Program, Quality Improvement and Research Pharmacist—Implementation Strategies and Preliminary Findings

Medication Utilisation Program, Quality Improvement and Research Pharmacist—Implementation Strategies and Preliminary Findings

Securing administrative leadership commitment for anticoagulation stewardship programs

Medication Use Evaluation of High-Dose Long-Term Opioid De-prescribing in Multiple Veterans Affairs Medical Centers

Contact Info

Product

Resources

About